Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Operating Leases (2021 - 2024)

Historic Operating Leases for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Burning Rock Biotech's Operating Leases fell 8032.66% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 8032.66%. This contributed to the annual value of $7.2 million for FY2024, which is 31290.32% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Operating Leases is $2.0 million, which was down 8032.66% from $2.5 million recorded in Q2 2025.
  • Burning Rock Biotech's Operating Leases' 5-year high stood at $29.7 million during Q4 2021, with a 5-year trough of $700000.0 in Q3 2023.
  • For the 5-year period, Burning Rock Biotech's Operating Leases averaged around $5.7 million, with its median value being $2.7 million (2022).
  • As far as peak fluctuations go, Burning Rock Biotech's Operating Leases soared by 138714.29% in 2024, and later tumbled by 8032.66% in 2025.
  • Burning Rock Biotech's Operating Leases (Quarter) stood at $29.7 million in 2021, then crashed by 75.18% to $7.4 million in 2022, then plummeted by 76.43% to $1.7 million in 2023, then soared by 312.9% to $7.2 million in 2024, then plummeted by 71.43% to $2.0 million in 2025.
  • Its Operating Leases stands at $2.0 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.7 million for Q1 2025.